Chaperone-mediated autophagy: Roles in neurodegeneration

Translational Neurodegeneration

Volumn 3, Issue 1, 2014, Pages

  Wang, Gang ^a   Mao, Zixu ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Chaperone mediated autophagy; Neurodegeneration; Parkinson's disease; Protein posttranslational modifications

Indexed keywords

ALPHA SYNUCLEIN; CHAPERONE; HEAT SHOCK COGNATE PROTEIN 70; HUNTINGTIN; LEUCINE RICH REPEAT KINASE 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2A; REGULATOR OF CALCINEURIN 1; REGULATOR PROTEIN; TAU PROTEIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

AGING; AUTOPHAGY; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; ENZYME SUBSTRATE; GENETIC RISK; HOMEOSTASIS; HUMAN; LYSOSOME; NERVE DEGENERATION; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

EID: 84907245350     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-3-20     Document Type: Review

References (66)

1. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007, 8(11):931-937. 10.1038/nrm2245, 17712358.
2. Kaushik S, Cuervo AM. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 2012, 22(8):407-417. 10.1016/j.tcb.2012.05.006, 3408550, 22748206.
3. Wang X, Pattison JS, Su H. Posttranslational modification and quality control. Circ Res 2013, 112(2):367-381. 10.1161/CIRCRESAHA.112.268706, 3566557, 23329792.
4. Orenstein SJ, Cuervo AM. Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Semin Cell Dev Biol 2010, 21(7):719-726. 10.1016/j.semcdb.2010.02.005, 2914824, 20176123.
5. Chiang HL, Dice JF. Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J Biol Chem 1988, 263(14):6797-6805.
6. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, Zha Z, Liu Y, Li Z, Xu Y, Wang G, Huang Y, Xiong Y, Guan KL, Lei QY. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011, 42(6):719-730. 10.1016/j.molcel.2011.04.025, 21700219.
7. Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, Martinez-Vincente M, Arrasate M, O'Rourke JG, Khashwji H, Lukacsovich T, Zhu YZ, Lau AL, Massey A, Hayden MR, Zeitlin SO, Finkbeiner S, Green KN, LaFerla FM, Bates G, Huang L, Patterson PH, Lo DC, Cuervo AM, Marsh JL, Steffan JS. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol 2009, 187(7):1083-1099. 10.1083/jcb.200909067, 2806289, 20026656.
8. Quintavalle C, Di Costanzo S, Zanca C, Tasset I, Fraldi A, Incoronato M, Mirabelli P, Monti M, Ballabio A, Pucci P, Cuervo AM, Condorelli G. Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells. J Cell Physiol 2014, 229(10):1359-1368. 10.1002/jcp.24569, 24477641.
9. Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, Mao Z. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323(5910):124-127. 10.1126/science.1166088, 2666000, 19119233.
10. Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004, 15(11):4829-4840. 10.1091/mbc.E04-06-0477, 524731, 15331765.
11. Arias E, Cuervo AM. Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 2011, 23(2):184-189. 10.1016/j.ceb.2010.10.009, 3078170, 21094035.
12. Kubota H. Quality control against misfolded proteins in the cytosol: a network for cell survival. J Biochem 2009, 146(5):609-616. 10.1093/jb/mvp139, 19737776.
13. Sooparb S, Price SR, Shaoguang J, Franch HA. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 2004, 65(6):2135-2144. 10.1111/j.1523-1755.2004.00639.x, 15149326.
14. Pemberton S, Madiona K, Pieri L, Kabani M, Bousset L, Melki R. Hsc70 protein interaction with soluble and fibrillar alpha-synuclein. J Biol Chem 2011, 286(40):34690-34699. 10.1074/jbc.M111.261321, 3186418, 21832061.
15. Li W, Yang Q, Mao Z. Chaperone-mediated autophagy: machinery, regulation and biological consequences. Cellular and molecular life sciences: CMLS 2011, 68(5):749-763. 10.1007/s00018-010-0565-6, 20976518.
16. Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A, Potolicchio I, Nieves E, Cuervo AM, Santambrogio L. Microautophagy of cytosolic proteins by late endosomes. Dev Cell 2011, 20(1):131-139. 10.1016/j.devcel.2010.12.003, 3025279, 21238931.
17. Arndt V, Dick N, Tawo R, Dreiseidler M, Wenzel D, Hesse M, Fürst DO, Saftig P, Saint R, Fleischmann BK, Hoch M, Höhfeld J. Chaperone-assisted selective autophagy is essential for muscle maintenance. Current biology: CB 2010, 20(2):143-148. 10.1016/j.cub.2009.11.022, 20060297.
18. Cuervo AM, Dice JF, Knecht E. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 1997, 272(9):5606-5615. 10.1074/jbc.272.9.5606, 9038169.
19. Cuervo AM, Knecht E, Terlecky SR, Dice JF. Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol 1995, 269(5 Pt 1):C1200-C1208.
20. Cuervo AM, Dice JF. Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci 2000, 113(Pt 24):4441-4450.
21. Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008, 28(18):5747-5763. 10.1128/MCB.02070-07, 2546938, 18644871.
22. Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, Tanaka Y, Lüllmann-Rauch R, Hartmann D, Heeren J, von Figura K, Knecht E, Saftig P. Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 2004, 15(7):3132-3145. 10.1091/mbc.E04-02-0103, 452571, 15121881.
23. Appelqvist H, Waster P, Kagedal K, Ollinger K. The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol 2013, 5(4):214-226. 10.1093/jmcb/mjt022, 23918283.
24. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J, Von Figura K, Saftig P. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 2002, 13(9):3355-3368. 10.1091/mbc.E02-02-0114, 124165, 12221139.
25. Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 2009, 10(9):623-635. 10.1038/nrm2745, 19672277.
26. Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Ballabio A. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 2011, 20(19):3852-3866. 10.1093/hmg/ddr306, 21752829.
27. Tanaka Y, Matsuwaki T, Yamanouchi K, Nishihara M. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice. Neuroscience 2013, 250:8-19.
28. Pena-Llopis S, Brugarolas J. TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy. Cell Cycle 2011, 10(23):3987-3988. 10.4161/cc.10.23.18251, 3272281, 22101272.
29. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A. TFEB links autophagy to lysosomal biogenesis. Sci 2011, 332(6036):1429-1433.
30. Tong J, Yan X, Yu L. The late stage of autophagy: cellular events and molecular regulation. Protein Cell 2010, 1(10):907-915. 10.1007/s13238-010-0121-z, 21204017.
31. Yang Z, Huang J, Geng J, Nair U, Klionsky DJ. Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol Biol Cell 2006, 17(12):5094-5104. 10.1091/mbc.E06-06-0479, 1679675, 17021250.
32. Yang Z, Klionsky DJ. Permeases recycle amino acids resulting from autophagy. Autophagy 2007, 3(2):149-150. 10.4161/auto.3631, 17204852.
33. Bandyopadhyay U, Sridhar S, Kaushik S, Kiffin R, Cuervo AM. Identification of regulators of chaperone-mediated autophagy. Mol Cell 2010, 39(4):535-547. 10.1016/j.molcel.2010.08.004, 2945256, 20797626.
34. Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res 2014, 24(1):92-104. 10.1038/cr.2013.153, 24281265.
35. Todde V, Veenhuis M, van der Klei IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 2009, 1792(1):3-13. 10.1016/j.bbadis.2008.10.016, 19022377.
36. Yabu T, Imamura S, Mohammed MS, Touhata K, Minami T, Terayama M, Yamashita M. Differential gene expression of HSC70/HSP70 in yellowtail cells in response to chaperone-mediated autophagy. FEBS J 2011, 278(4):673-685. 10.1111/j.1742-4658.2010.07989.x, 21205201.
37. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting Proteostasis for Disease Intervention. Science 2008, 319(5865):916-919. 10.1126/science.1141448, 18276881.
38. Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci U S A 2006, 103(15):5805-5810. 10.1073/pnas.0507436103, 1458654, 16585521.
39. Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell 2008, 19(5):2179-2192. 10.1091/mbc.E07-11-1155, 2366850, 18337468.
40. Massey AC, Follenzi A, Kiffin R, Zhang C, Cuervo AM. Early cellular changes after blockage of chaperone-mediated autophagy. Autophagy 2008, 4(4):442-456. 10.4161/auto.5654, 18253088.
41. Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 2009, 33(4):517-527. 10.1016/j.molcel.2009.01.021, 2669153, 19250912.
42. Cuervo AM, Dice JF. Age-related decline in chaperone-mediated autophagy. J Biol Chem 2000, 275(40):31505-31513. 10.1074/jbc.M002102200, 10806201.
43. Gao L, She H, Li W, Zeng J, Zhu J, Jones DP, Mao Z, Gao G, Yang Q. Oxidation of Survival Factor MEF2D in Neuronal Death and Parkinson's Disease. Antioxid Redox Signal 2014, 20(18):2936-2948. 10.1089/ars.2013.5399, 24219011.
44. Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 2010, 67(12):1464-1472.
45. Koga H, Martinez-Vicente M, Arias E, Kaushik S, Sulzer D, Cuervo AM. Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease. The J Neurosci: Official J Soc Neurosci 2011, 31(50):18492-18505.
46. Modgil S, Lahiri DK, Sharma VL, Anand A. Role of early life exposure and environment on neurodegeneration: implications on brain disorders. Transl Neurodegeneration 2014, 3:9.
47. McInnes J. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl Neurodegeneration 2013, 2(1):12.
48. Marin C, Aguilar E. In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression. Neurochem Int 2011, 58(4):521-526. 10.1016/j.neuint.2011.01.010, 21237229.
49. Dohi E, Tanaka S, Seki T, Miyagi T, Hide I, Takahashi T, Matsumoto M, Sakai N. Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival. Neurochem Int 2012, 60(4):431-442. 10.1016/j.neuint.2012.01.020, 22306777.
50. Sala G, Arosio A, Stefanoni G, Melchionda L, Riva C, Marinig D, Brighina L, Ferrarese C. Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition. BioMed Res Int 2013, 2013:846725. 3745903, 23984410.
51. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Sci 2004, 305(5688):1292-1295.
52. Kabuta T, Furuta A, Aoki S, Furuta K, Wada K. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 2008, 283(35):23731-23738. 10.1074/jbc.M801918200, 3259779, 18550537.
53. Wang Y, Kruger U, Mandelkow E, Mandelkow EM. Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy. Neurodegener Dis 2010, 7(1-3):103-107.
54. Rodriguez-Navarro JA, Cuervo AM. Dietary lipids and aging compromise chaperone-mediated autophagy by similar mechanisms. Autophagy 2012, 8(7):1152-1154. 3429556, 22653298.
55. Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 2008, 118(2):777-788. 2157565, 18172548.
56. Qi L, Zhang XD. Role of chaperone-mediated autophagy in degrading Huntington's disease-associated huntingtin protein. Acta Biochim Biophys Sin 2014, 46(2):83-91. 10.1093/abbs/gmt133, 24323530.
57. Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM, Cuervo AM, Mandelkow E. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 2009, 18(21):4153-4170. 10.1093/hmg/ddp367, 2758146, 19654187.
58. Kabuta T, Wada K. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Autophagy 2008, 4(6):827-829. 10.4161/auto.6560, 18635949.
59. Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, Cortes E, Honig LS, Dauer W, Consiglio A, Raya A, Sulzer D, Cuervo AM. Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 2013, 16(4):394-406. 10.1038/nn.3350, 3609872, 23455607.
60. Pan PY, Yue Z. Genetic causes of Parkinson's disease and their links to autophagy regulation. Parkinsonism Relat Disord 2014, 20(Suppl 1):S154-S157.
61. Liu H, Wang P, Song W, Sun X. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J: Official publication Fed Am Soc Exp Biology 2009, 23(10):3383-3392.
62. Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 2006, 73:205-235.
63. Kaushik S, Cuervo AM. Methods to monitor chaperone-mediated autophagy. Methods Enzymol 2009, 452:297-324.
64. Sotelo J, Briceno E, Lopez-Gonzalez MA. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2006, 144(5):337-343. 10.7326/0003-4819-144-5-200603070-00008, 16520474.
65. Kimura T, Takabatake Y, Takahashi A, Isaka Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res 2013, 73(1):3-7. 10.1158/0008-5472.CAN-12-2464, 23288916.
66. Sala G, Stefanoni G, Arosio A, Riva C, Melchionda L, Saracchi E, Fermi S, Brighina L, Ferrarese C. Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease. Brain Res 2014, 1546:46-52.